Uncommon secured $30 million in Series A, led by Balderton Capital and Lowercarbon Capital, joined by Redalpine, East Alpha and angel investors Biotech Food Industry Manufacturing Investments 05 June 2023 Share:
Round value (USD): 30m Round investors: Balderton Capital Redalpine Sam Altman Lowercarbon Capital Dismatrix/Planthesis Fund East Alpha Max Altman Company: Uncommon Industry: Biotech Food Industry Manufacturing
Apollo Therapeutics raised $33.5m in an extended Series C funding led by Patient Square Capital, joined by M&G and Rock Springs Capital. Biotech Manufacturing Pharma Investments 03 December 2023
ViaNautis to raise £20M series A with UCB Ventures, BGF Ventures, 4BIO Capital Biotech Health services Manufacturing Pharma Investments 10 November 2023
Sitryx Therapeutics in a £32M series A led by Oxford Science Enterprises Biotech Health services Manufacturing Pharma Investments 01 September 2023
Enough raised €40M in Series C led by World Fund and CPT Capital. Agriculture Food Industry Manufacturing Investments 10 August 2023
Chemify raised $43 million in a round led by Triatomic Capital, joined by Horizon Ventures, Rocketship Ventures, Possible Ventures, Alix Ventures, Eos Biotech Hardware Manufacturing Software Services Investments 30 July 2023